JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2007, 56(6):276-279

Experience with ciclesonide in patients with mild persistent bronchial asthma

L. Bartošíková1, J. Nečas1, L. Fráňa2, T. Bartošík3
1 Univerzita Palackého, Lékařská fakulta, Ústav fyziologie, Olomouc
2 Dům zdraví, Velké Meziříčí
3 Anesteziologicko-resuscitační klinika FN U sv. Anny v Brně

The study aimed to monitor the effectiveness and safety of the treatment with ciclesonide, administered once a day in a 160 μg dose, over a 3-month period, to a group of 100 patients diagnosed with mild persistent bronchial asthma with deterioration of problems after exercise. The results of the study prove significant positive effects of the preparation used. A significant improvement of FEV1 and PEF values was observed, as well as a statistically significant remission of both day and nocturnal symptoms of the disease, a significantly lower consumption of shortacting β2-sympathomimetics, and an improvement of all evaluated data relating to the quality of life of the asthmatic patients. No adverse effects were registered.

Keywords: ciclesonide; inhaled corticosteroids; bronchial asthma

Received: June 15, 2007; Accepted: August 14, 2007; Published: June 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bartošíková L, Nečas J, Fráňa L, Bartošík T. Experience with ciclesonide in patients with mild persistent bronchial asthma. Čes. slov. farm. 2007;56(6):276-279.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Kašák, V.: Remedia, 1999; 9, 320-322. Go to original source...
    2. Salajka, F.: Remedia, 2005; 15, 316-322. Go to original source... Go to PubMed...
    3. Belvisi, M. G., Bundschuh, D. S., Stoeck, M. et al.: J. Pharmacol. Exp. Ther., 2005; 314, 568-574. Go to original source... Go to PubMed...
    4. Suchopár, J., Prázdnovcová, L., Ivanovic, N.: Remedia, 2005; 15, 307-309.
    5. Reynolds, N. A., Scott, L. J.: Drugs, 2004; 64, 511-519. Go to original source... Go to PubMed...
    6. Larsen, B. B., Nielsen, L. P., Engelstatter, R. et al.: Allergy, 2003; 58, 207-212. Go to original source... Go to PubMed...
    7. Kašák, V.: Farmakoterapie, 2006; 2, 18-25. Go to original source... Go to PubMed...
    8. Bordley, J. E., Carey, R. A., Harvey, A. M. et al.: Bull. John Hopkins Hosp., 1949; 85, 396-398.
    9. Ayres, J. G.: Thorax, 1977; 52(Suppl.1).
    10. Vondra, V.: ČSL JEP, Praha, 1996.
    11. Kolek, V.: Respirace, 1997; 3, 8-12.
    12. Pedersen, S., OęByrne, P.: Allergy, 1997; 52 (Suppl 39), 1-34. Go to original source... Go to PubMed...
    13. Jackson, W.: Early intervention in astma. Harwel, Clinical Vision Ltd, 1997.
    14. Haathela, T.: N. Engl. J. Med., 1991; 325, 388-392.
    15. Haathela, T.: N. Engl. J. Med., 1994; 331, 700-705. Go to original source... Go to PubMed...
    16. Engelstätter, R., Langdon, C., Bethke, T: Am. J. Respir. Crit. Care Med., 2002; 165, A776.
    17. Chapman, K. R., Patel, P., Boulet, L. P.: Eur. Respir. J., 2002; 20(Suppl), 373-374.
    18. Global Initiative for astma. (Pendant, C., et al., ed.), NIH Publication No. 95-3659, 1995, s.176.
    19. Geddes, D. M.: Thorax, 1992; 47, 404-407. Go to original source... Go to PubMed...

    Return to the content


    Czech and Slovak Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.